Thurs 10/2, 4pm – 5pm EST
Forum: Cultivating Innovation & Entrepreneurship
Sue Siegel leads two of GE’s growth and innovation initiatives as CEO, GE Ventures & healthymagination. GE Ventures is GE’s venture arm investing in the start-up ecosystem across the Healthcare, Energy, IT, and Advanced Manufacturing industries. Healthymagination, is the company-wide initiative that harnesses innovation and partnership to drive better health outcomes.
Sue is a 25+-year business leader with corporate and venture capital experience.
Previously, as a financial VC, Sue led investments in personalized medicine, digital health, and life sciences at Silicon Valley-based Mohr Davidow Ventures. Before her VC years, she dedicated 20+ years driving the growth of breakthrough technologies at Bio-Rad, DuPont, Amersham, and Affymetrix (NASDAQ: AFFX). As President and Board Member of Affymetrix, she built shareholder value by leading its transformation from a pre-revenue start up into a global, multi-billion dollar market cap genomics leader.
Sue has served on over two dozen private and public corporate boards. She currently serves on the Boards of: the National Venture Capital Association, NIH’s National Center for Advancing Translational Sciences-Cures Acceleration Network, Stanford Hospital Board’s IT Committee, Harvard Partners’ Innovation Advisory Board, the Cleveland Clinic’s Innovation Council, and serves on the Executive Committee of Santa Clara University’s Center for Science, Technology, and Society’s Advisory Board. She is a President’s Circle member of the National Academies of Science, a member of YPO-WPO, Women Corporate Directors, and a Henry Crown Fellow of the Aspen Institute. In the bestselling business book: Multipliers: How The Best Leaders Make Everyone Smarter, Sue was a featured “Multiplier”. She was recognized as one of “The 100 Most Influential Women in Silicon Valley”.
Sue lives in Silicon Valley with her husband and her two sons. When not working, you might find her hiking the scenic trails of Northern California.